NIAID R01 Grant: Therapeutic Strategies for Converging TB/T2DM/HIV Epidemics
SynopsisVersion HistoryRelated DocumentsPackage This R01 grant from the National Institute of Allergy and Infectious Diseases (NIAID) invites applications for innovative research aimed at understanding immune dysregulation in the context of converging Type 2 Diabetes Mellitus (T2DM), pre-diabetes, Tuberculosis (TB), and HIV epidemics. The grant seeks to elucidate how T2DM and pre-diabetes-induced immune dysfunction increases the risk of latent TB re-activation and exacerbates active TB disease, leading to more frequent treatment failure, [...]